References
World Health Organisation. Tuberculosis: infection and transmission [online]. Available from URL: http://who.int [Accessed 2006 May 18]
Van de Brande. Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly. Drugs Aging 2005; 22(8): 663–86
Skevaki CL, Kafetzis DA. Tuberculosis in neonates and infants: epidemiology, pathogenesis, clinical manifestations, diagnosis, and management issues. Pediatr Drugs 2005; 7(4): 219–34
Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med 1980; 1: 231–41
American Thoracic Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003; 167: 603–62
Joint Tuberculosis Committee of the British Thoracic Society. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations 1998. Thorax 1998; 53: 536–48
American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000; 161: S221–47
Grosset J. Bacteriologic basis of short-course chemotherapy for tuberculosis. Clin Chest Med 1980; 1: 231–41
British national formulary. No. 51. London: The Pharmaceutical Press, 2006 Mar
Ginsburg AS, Grosset JH, Bishai WR. Fluoroquinolones, tuberculosis and resistance. Lancet Infect Dis 2003; 3: 432–42
Frieden TR, Sterling TR, Munsiff SS, et al. Tuberculosis. Lancet 2003; 362(9387): 887–99
Horsburgh Jr CR, Feldman S, Ridzon R. Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 2000; 31: 633–9
Pablos-Méndez A, Knirsch CA, Barr RG, et al. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 1997; 102: 164–70
Van den Brande P, Van Steenbergen W, Vervoort G, et al. Aging and hepatotoxicity of isoniazid and rifampin in pulmonary tuberculosis. Am J Respir Crit Care Med 1995; 152: 1705–8
Jasmer RM, Nahid P, Hopewell PC. Latent tuberculosis infection. N Engl J Med 2002; 347: 1860–6
Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax 2000; 55: 887–901
International Union Against Tuberculosis and Lung Disease. Criteria for discontinuation of vaccination programs using Bacille Calmette-Guérin (BCG) in countries with a low prevalence of tuberculosis. Tuber Lung Dis 1994; 75: 179–80
Rights and permissions
About this article
Cite this article
Effective identification, treatment and prevention is key in the war on tuberculosis. Drugs Ther. Perspect 22, 8–12 (2006). https://doi.org/10.2165/00042310-200622110-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-200622110-00003